530317 — Godavari Drugs Cashflow Statement
0.000.00%
- IN₹731.29m
- IN₹1.32bn
- IN₹1.13bn
- 62
- 62
- 30
- 52
Annual cashflow statement for Godavari Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 102 | 116 | 108 | 138 | 128 |
Deferred Taxes | |||||
Non-Cash Items | -4.1 | -2.76 | -6.55 | -6.17 | -9.77 |
Other Non-Cash Items | |||||
Changes in Working Capital | -81.1 | 4.88 | 32 | 52 | -6.32 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13.3 | 112 | 132 | 184 | 112 |
Capital Expenditures | -16.7 | -52.5 | -93 | -132 | -200 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 4.22 | 2.74 | 6.58 | -0.202 | 4.86 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.5 | -49.7 | -86.4 | -132 | -195 |
Financing Cash Flow Items | -31.9 | -29.1 | -39.4 | -48.7 | -46.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.34 | -56.2 | -37.7 | -56.5 | 80.7 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.12 | 6.38 | 8.08 | -4.62 | -2.5 |